EUVIMEDEUVIMED entdecken
Open Access

Optimal Cutoff Values and Utility of High-Sensitivity Troponin T and NT-proBNP for the Risk Stratification of Patients with Acute Pulmonary Embolism

Timothy M Matthews iD, Gregory A Peters, Grace Wang, Nora Horick, Kyle E Chang, Savanah Harshbarger, Christiana Prucnal, Drew A Birrenkott, Karsten Stannek, Eun Sang Lee, Isabel Dhar iD, Jesse O Wrenn und 2 weitere

Clinical Chemistry · 2025

DOI: 10.1093/clinchem/hvae212 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Chemistry, 2025. Verfasst von Timothy M Matthews und 13 weiteren Autor:innen. Beteiligte Einrichtung: Center for Vascular Emergencies, Department of Emergency Medicine, Massachusetts General Hospital, Boston, MA, United States. Hauptthemen laut MEDLINE: Natriuretic Peptide, Brain, Pulmonary Embolism, Troponin T, Peptide Fragments. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Guidelines recommend using high-sensitivity troponin T (hsTnT) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) to risk stratify hemodynamically stable patients with acute pulmonary embolism (PE). However, there are no evidence-based cutoff values defined for this clinical application.

Methods

We performed a single-center, retrospective cohort study of patients with imaging-confirmed PE and hsTnT and/or NT-proBNP (ElecsysTM, Roche) measured 12 h before or 24 h after PE Response Team (PERT) activation. We excluded hypotensive patients. Our primary outcome was a composite of adverse outcomes or critical interventions within 7 days. We calculated the area under the receiver operating curve (AUC, ROC) for hsTnT and NT-proBNP and determined the optimal cutoffs using the distance from (0,1). We performed a subgroup analysis on patients with PE and right ventricular dysfunction on imaging.

Results

Two hundred thirty-four patients were included in the hsTnT analysis, and 727 in the NT-proBNP analysis. Mean age was 62 years (SD = 17) and 47% were female. The AUC for hsTnT was 0.64 (95% CI, 0.56–0.71) with an optimal cutoff of 46 ng/L, corresponding to a sensitivity of 59% (95% CI, 49–69) and a specificity of 61% (95% CI, 53–69). The AUC for NT-proBNP was 0.56 (95% CI, 0.51–0.61) with an optimal cutoff of 1092 pg/mL, corresponding to a sensitivity of 53% (95% CI, 45–61) and a specificity of 59% (95% CI, 55–63).

Conclusion

We identified an optimal cutoff of 46 ng/L for hsTnT and 1092 pg/mL for NT-proBNP, though the AUC for both markers suggests low to moderate performance for the risk stratification of initially hemodynamically stable PERT patients. Use of these biomarkers to risk stratify PE may require reconsideration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Natriuretic Peptide, BrainPulmonary EmbolismTroponin TPeptide FragmentsHumansFemaleMaleMiddle AgedRetrospective StudiesAgedBiomarkersRisk AssessmentAcute DiseaseROC CurveCohort Studies

Substanzen

Natriuretic Peptide, BrainTroponin TPeptide Fragmentspro-brain natriuretic peptide (1-76)Biomarkers

Autor:innen und Institutionen

  • Center for Vascular Emergencies, Department of Emergency Medicine, Massachusetts General Hospital, Boston, MA, United States.
  • Department of Emergency Medicine, Harvard Medical School, Boston, MA, United States.
  • Department of Emergency Medicine, Brigham and Women's Hospital, Boston, MA, United States.
  • Department of Biostatistics, Massachusetts General Hospital, Boston, MA, United States.
  • California University of Science and Medicine, Colton, CA, United States.
  • Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.

ORCID-Profile: Timothy M Matthews, Isabel Dhar

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Matthews, T. M., Peters, G. A., Wang, G., Horick, N., Chang, K. E., Harshbarger, S., Prucnal, C., Birrenkott, D. A., Stannek, K., Lee, E. S., Dhar, I., Wrenn, J. O., Stubblefield, W. B., & Kabrhel, C. (2025). Optimal Cutoff Values and Utility of High-Sensitivity Troponin T and NT-proBNP for the Risk Stratification of Patients with Acute Pulmonary Embolism. Clinical Chemistry. https://doi.org/10.1093/clinchem/hvae212

Vancouver

Matthews TM, Peters GA, Wang G, Horick N, Chang KE, Harshbarger S, et al. Optimal Cutoff Values and Utility of High-Sensitivity Troponin T and NT-proBNP for the Risk Stratification of Patients with Acute Pulmonary Embolism. Clinical Chemistry. 2025. doi:10.1093/clinchem/hvae212

BibTeX
@article{Matthews2025,
  author = {Matthews, Timothy M and Peters, Gregory A and Wang, Grace and Horick, Nora and Chang, Kyle E and Harshbarger, Savanah and Prucnal, Christiana and Birrenkott, Drew A and Stannek, Karsten and Lee, Eun Sang and Dhar, Isabel and Wrenn, Jesse O and Stubblefield, William B and Kabrhel, Christopher},
  title = {Optimal Cutoff Values and Utility of High-Sensitivity Troponin T and NT-proBNP for the Risk Stratification of Patients with Acute Pulmonary Embolism},
  journal = {Clinical Chemistry},
  year = {2025},
  doi = {10.1093/clinchem/hvae212}
}
Kostenlos starten →